Literature DB >> 16114805

Palliative pain management: when both pain and suffering hurt.

Florian Strasser1, Paul Walker, Eduardo Bruera.   

Abstract

Patients with advanced cancer frequently experience intractable pain without sufficient response to a conventional pharmacological approach. One reason for refractory pain at the end of life can be the bidirectional nature of pain and suffering. Three terminally ill patients were assessed using a multidimensional palliative pain concept, including sensory, affective, cognitive, and existential components. In these patients, resistant pain did not equal insufficient eradication of the nociceptive input, but also suffering. Unrelieved emotions, depressive or anxious symptoms, delirium, difficulties communicating, or chemical coping influenced the expression of pain, illuminating the phenomenon of somatization. Palliative pain treatment integrated analgesic treatments, psychological, rehabilitative, and existential interventions, in consideration of individual expectations and outcomes. With the disciplined assessment and alternative multidisciplinary palliative approach, the quality of life of three terminally ill cancer patients with intractable pain could be enhanced, and unnecessary interventions and escalation of medications avoided.

Entities:  

Mesh:

Year:  2005        PMID: 16114805

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  13 in total

Review 1.  Drug therapy optimization at the end of life.

Authors:  Alfonso J Cruz-Jentoft; Benoit Boland; Lourdes Rexach
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  Promoting science in a pragmatic world: not (yet) time for partial opioid rotation.

Authors:  Florian Strasser
Journal:  Support Care Cancer       Date:  2005-07-12       Impact factor: 3.603

3.  Patient-controlled analgesia at the end of life at a pediatric oncology institution.

Authors:  Doralina L Anghelescu; Jennifer M Snaman; Luis Trujillo; April D Sykes; Y Yuan; Justin N Baker
Journal:  Pediatr Blood Cancer       Date:  2015-03-27       Impact factor: 3.167

4.  Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients.

Authors:  Rony Dev; Henrique A Parsons; Shana Palla; J Lynn Palmer; Egidio Del Fabbro; Eduardo Bruera
Journal:  Cancer       Date:  2011-03-28       Impact factor: 6.860

5.  Psychological variables potentially implicated in opioid-related mortality as observed in clinical practice.

Authors:  Steven D Passik; Amy Lowery
Journal:  Pain Med       Date:  2011-06       Impact factor: 3.750

Review 6.  Pediatric Oncology: Managing Pain at the End of Life.

Authors:  Jennifer M Snaman; Justin N Baker; Jennifer H Ehrentraut; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

7.  Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use.

Authors:  Henrique A Parsons; Marvin Omar Delgado-Guay; Badi El Osta; Ray Chacko; Valerie Poulter; J Lynn Palmer; Eduardo Bruera
Journal:  J Palliat Med       Date:  2008-09       Impact factor: 2.947

8.  Spousal suffering and partner's depression and cardiovascular disease: the Cardiovascular Health Study.

Authors:  Richard Schulz; Scott R Beach; Randy S Hebert; Lynn M Martire; Joan K Monin; Connie A Tompkins; Steven M Albert
Journal:  Am J Geriatr Psychiatry       Date:  2009-03       Impact factor: 4.105

9.  Dementia patient suffering and caregiver depression.

Authors:  Richard Schulz; Kathleen A McGinnis; Song Zhang; Lynn M Martire; Randy S Hebert; Scott R Beach; Bozena Zdaniuk; Sara J Czaja; Steven H Belle
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Apr-Jun       Impact factor: 2.703

10.  The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia.

Authors:  Shelley R Salpeter; Jacob S Buckley; Eduardo Bruera
Journal:  J Palliat Med       Date:  2013-04-04       Impact factor: 2.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.